Abstract
The impact of antiretroviral therapy (ART) on opportunistic conditions in HIV patients continues to evolve. We specifically studied the changing epidemiology of oropharyngeal candidiasis (OPC) in 215 HIV/AIDS patients. Status of yeast colonization was assessed from oral rinse samples, and preliminary yeast identification was made using CHROMagar Candida and confirmed with standard microbiological techniques and/or molecular sequencing. Susceptibility to fluconazole was determined by CHROMagar Candida agar dilution screening and CLSI broth microdilution. 176 (82%) patients were colonized and 59 (27%) patients had symptomatic OPC. Candida albicans was the most prevalent species, though C. glabrata and C. dubliniensis were detected in 29% of isolates. Decreased fluconazole susceptibility occurred in 10% of isolates. Previous ART reduced the risk of OPC, while smoking increased the risk of colonization. Oral yeast colonization and symptomatic infection remain common even with advances in HIV therapy. C. albicans is the most common species, but other yeasts are prevalent and may have decreased susceptibility to fluconazole.
| Original language | English (US) |
|---|---|
| Article number | 262471 |
| Journal | AIDS Research and Treatment |
| Volume | 2012 |
| DOIs | |
| State | Published - 2012 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Immunology and Allergy
- Infectious Diseases
- Dermatology
Cite this
The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy. / Patel, Payal K.; Erlandsen, Joshua E.; Kirkpatrick, William R.; Berg, Deborah K.; Westbrook, Steven D.; Louden, Christopher; Cornell, John E.; Thompson, George Richard; Vallor, Ana C.; Wickes, Brian L.; Wiederhold, Nathan P.; Redding, Spencer W.; Patterson, Thomas F.
In: AIDS Research and Treatment, Vol. 2012, 262471, 2012.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy
AU - Patel, Payal K.
AU - Erlandsen, Joshua E.
AU - Kirkpatrick, William R.
AU - Berg, Deborah K.
AU - Westbrook, Steven D.
AU - Louden, Christopher
AU - Cornell, John E.
AU - Thompson, George Richard
AU - Vallor, Ana C.
AU - Wickes, Brian L.
AU - Wiederhold, Nathan P.
AU - Redding, Spencer W.
AU - Patterson, Thomas F.
PY - 2012
Y1 - 2012
N2 - The impact of antiretroviral therapy (ART) on opportunistic conditions in HIV patients continues to evolve. We specifically studied the changing epidemiology of oropharyngeal candidiasis (OPC) in 215 HIV/AIDS patients. Status of yeast colonization was assessed from oral rinse samples, and preliminary yeast identification was made using CHROMagar Candida and confirmed with standard microbiological techniques and/or molecular sequencing. Susceptibility to fluconazole was determined by CHROMagar Candida agar dilution screening and CLSI broth microdilution. 176 (82%) patients were colonized and 59 (27%) patients had symptomatic OPC. Candida albicans was the most prevalent species, though C. glabrata and C. dubliniensis were detected in 29% of isolates. Decreased fluconazole susceptibility occurred in 10% of isolates. Previous ART reduced the risk of OPC, while smoking increased the risk of colonization. Oral yeast colonization and symptomatic infection remain common even with advances in HIV therapy. C. albicans is the most common species, but other yeasts are prevalent and may have decreased susceptibility to fluconazole.
AB - The impact of antiretroviral therapy (ART) on opportunistic conditions in HIV patients continues to evolve. We specifically studied the changing epidemiology of oropharyngeal candidiasis (OPC) in 215 HIV/AIDS patients. Status of yeast colonization was assessed from oral rinse samples, and preliminary yeast identification was made using CHROMagar Candida and confirmed with standard microbiological techniques and/or molecular sequencing. Susceptibility to fluconazole was determined by CHROMagar Candida agar dilution screening and CLSI broth microdilution. 176 (82%) patients were colonized and 59 (27%) patients had symptomatic OPC. Candida albicans was the most prevalent species, though C. glabrata and C. dubliniensis were detected in 29% of isolates. Decreased fluconazole susceptibility occurred in 10% of isolates. Previous ART reduced the risk of OPC, while smoking increased the risk of colonization. Oral yeast colonization and symptomatic infection remain common even with advances in HIV therapy. C. albicans is the most common species, but other yeasts are prevalent and may have decreased susceptibility to fluconazole.
UR - http://www.scopus.com/inward/record.url?scp=84873801194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873801194&partnerID=8YFLogxK
U2 - 10.1155/2012/262471
DO - 10.1155/2012/262471
M3 - Article
C2 - 22970352
AN - SCOPUS:84873801194
VL - 2012
JO - AIDS Research and Treatment
JF - AIDS Research and Treatment
SN - 2090-1240
M1 - 262471
ER -